Timothy Francis Cloughesy, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer L. Clarke, Joe S. Mendez, Liam Welsh, Warren P. Mason, Andreas Felix Hottinger, Juan Manuel Sepúlveda, Wolfgang Wick, Riccardo Soffietti, Dan Zhao, Judy Jimenez, Edward Espinal Dominguez, Islam Hassan, Patrick Y. Wen, Ingo K. Mellinghoff. "A global, randomized, double-blinded, phase 3 trial of vorasidenib vs placebo in patients with grade 2 glioma with an
                    <i>IDH1/2</i>
                    mutation (INDIGO): Updated efficacy and safety.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2010